Composition
- Active ingredients
- ONDANSETRON HYDROCHLORIDE EQ 4MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ONDANSETRON HYDROCHLORIDE EQ 24MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020103-003 · Discontinued
- ONDANSETRON HYDROCHLORIDE EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020103-001 · Discontinued
- ONDANSETRON HYDROCHLORIDE EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020103-002 · Discontinued
- ONDANSETRON HYDROCHLORIDE EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA020007-001 · Discontinued
- ONDANSETRON HYDROCHLORIDE EQ 4MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SolutionThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020605.
At a glance
- Brand name
- Zofran
- Active substance
- ondansetron hydrochloride
- Route
- Oral
- Dosage form
- Solution
- Applicant
- Sandoz
- Status
- Discontinued
- FDA approval
- 24 Jan 1997
- Application
- NDA020605-001